Posts by Kayt Sukel
A Failed Clinical Trial of a Digital App for Migraine: Where to from Here?
M-sense Migräne did not perform better than a control app on the study’s primary outcome, nor on most secondary outcomes. What does the future hold for digital tools to manage migraine?
Flags for Headache: Raising Awareness and Building Momentum for Policy Change
The Alliance for Headache Disorders Advocacy and the Headache Alliance produced a unique visual installation on the historic National Mall in Washington, DC.
Optimizing the Treatment of Migraine: A Conversation with Richard Lipton
In this Migraine Science Collaborative interview, Dr. Lipton discusses the questions he’s most interested in as a headache researcher, key results from past migraine clinical trials, what the future may look like for additional trials, and more.
Anti-CGRP Treatment Improves Prodromal Symptoms of Migraine
A new phase 3 clinical trial shows that ubrogepant, a CGRP receptor antagonist, alleviates photophobia, fatigue, neck pain, and other prodromal symptoms.
New Insight into the Immune System’s Role in Cluster Headache
A prospective case-control study reveals changes in cytokine levels in chronic CH, episodic CH in bout, and episodic CH in remission, compared to healthy controls.
Taking the Long View to Understand CACNA1A-Related Hemiplegic Migraine
A new longitudinal study of a rare type of migraine suggests every attack should be treated as potentially life threatening.
Making Progress: The Australian Treasury’s Loss Becomes the Headache Field’s Gain – A Chat with Peter Goadsby
In this Migraine Science Collaborative interview, Dr. Goadsby discusses the surprising way he got into medicine, how his work on CGRP started from a research conference conversation, and why physicians need to get their own house in order to reduce headache stigma.
An Increased Risk of Suicide across Medical Conditions – Including Migraine
A new analysis considers 31 medical conditions, including neurological conditions like migraine. The elevated suicide risk in almost all of them increased with more severe disability.
A Strategy to Shape the HEAL Initiative’s Future
The National Institutes of Health is taking an all-hands-on-deck approach to guide where the HEAL initiative to advance pain research and treatment should go next.
Addressing Migraine Stigma through Advocacy: An Interview with William B. Young
In this Migraine Science Collaborative interview, Dr. William B. Young discusses the problem of migraine stigma, what needs to happen to improve it, and how his advocacy efforts have changed his clinical work for the better, among other topics.